Showing results (481-490 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|December 1, 2005
Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategyPathirage G Dharmawardana, Benedetta Peruzzi, Alessio Giubellino, et al.
Anti-Cancer Drugs|December 1, 2005
Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cellsRichard J Santen, Amanda R Lynch, Lindsey R Neal, et al.
Anti-Cancer Drugs|December 1, 2005
Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines: comparisons with the National Cancer Institute dataKarin Bracht, Boubakari, Renate Grünert, et al.
Anti-Cancer Drugs|December 1, 2005
Plasma kinetics of procarbazine and azo-procarbazine in humansRainer Preiss, Frank Baumann, Ralf Regenthal, et al.
Anti-Cancer Drugs|December 1, 2005
Irinotecan (CPT-11) combined with bolus 5-fluorouracil/leucovorin (Saltz regimen) as first-line chemotherapy of patients with advanced colorectal cancerRamón Barceló, Guillermo López Vivanco, Fernando Rivera, et al.
Anti-Cancer Drugs|January 30, 2010
Renal cell carcinoma: complete responseOvidio Fernández Calvo, Diana Dopico Vázquez, Margarita Reboredo López, et al.
Anti-Cancer Drugs|January 30, 2010
The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2alpha in leukemia cellsYanchun Li, Rui Wang, Enlong Ma, et al.
Anti-Cancer Drugs|June 21, 2018
Construction and characterization of regulated cycle inhibiting factors induced upon Tet-On system in human colon cancer cell linesLiang Liu, Jianjiao Ni, Junhua Zhang, et al.
Anti-Cancer Drugs|April 19, 2019
Poly (ADP-ribose) polymerase inhibitors combined with other small-molecular compounds for the treatment of ovarian cancerLanlan Liu, Peng Liu, Zhiquan Liang, et al.
Anti-Cancer Drugs|June 1, 1992
Effects of 5-aza-2'-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cellsB T Doré, R L Momparler
Pageof 464